EGCG for the Prevention and Treatment of TIPN

Clinical trial NCT06524609 · UNKNOWN

Trial details

NCT number: NCT06524609
Sponsor: Han Xi Zhao
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy

Start date: 2023-11-30
Primary completion: 2024-11-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.